Wilmington Trust’s Bristol-Myers Squibb BMY Stock Holding History

Wilmington Trust’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	$38M	Sell	784,306 -39,611	-5%	-$1.95M	0.63%	38
2014 Q1	$42.8M	Sell	823,917 -17,367	-2%	-$924K	0.74%	30
2013 Q4	$44.7M	Buy	841,284 +3,859	+0.5%	+$197K	0.76%	26
2013 Q3	$38.8M	Sell	837,425 -8,897	-1%	-$391K	0.68%	28
2013 Q2	$37.8M	Buy	+846,322	New	+$36.7M	0.76%	28

Other funds holding BMY

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Wilmington Trust's BMY Position: Q2 2014 in Review

Wilmington Trust reduced its Bristol-Myers Squibb (BMY) stake by 4.8% in Q2 2014, selling an estimated $1.95M and leaving 784,306 shares worth $38M. The position accounts for 0.63% of the portfolio, ranked #38.

Wilmington Trust first reported a position in BMY in Q2 2013 and has held it in 5 quarters since. The position peaked at $44.7M in Q4 2013. 1,303 funds tracked by Wall St. Rank hold BMY as of Q2 2014.

Wilmington Trust held 784,306 shares of Bristol-Myers Squibb worth $38M as of Q2 2014.
Wilmington Trust sold 39,611 Bristol-Myers Squibb shares in Q2 2014, an estimated $1.95M.
Bristol-Myers Squibb made up 0.63% of Wilmington Trust's portfolio in Q2 2014, its #38 holding.
Wilmington Trust first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 5 quarters since.
Wilmington Trust's Bristol-Myers Squibb position peaked at $44.7M in Q4 2013.
1,303 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2014.

Based on Wilmington Trust's 13F filing for Q2 2014, filed 13 Aug 2014.